Release date:2016-05-13  Release:


Associate Professor of Microbial pharmacy

School of Life Science and Technology

Phone: 86-25-86185412


Research Summary

Associate professor Chen’s research focuses on antimicrobial pharmacodynamics, especially the activities against drug-resistant bacteria, screening of bioactive substances from microorganisms andmicrobial quality controlof pharmaceuticals.


2001-2005, Ph.D, Microbial and Biochemical Pharmacy, China Pharmaceutical University

1993-1996, M.S., Department of Pharmaceutical Analysis, China Pharmaceutical University

1986-1990, B.S., Microbiology, Fudan University

Academic Experience

2004-  Associate Professor of Microbial and Biochemical Pharmacy, Department of Microbiology, China Pharmaceutical University

2012-2013 Visiting Scholar/Research Fellow of Microbial and Biochemical Pharmacy,Harvard Medical School/ Massachusetts General Hospital

1996-2004 Lecturer of Microbial and Biochemical Pharmacy,Department of Microbiology, China Pharmaceutical University

Awards and Honors

2011 First Prize, for Teaching Achievement Award, China Pharmaceutical University

2008 First Prize, for Backbone teacher of Youth Project, Jiangsu Province

2005 First Prize, for Undergraduate Teaching Excellence Award, China Pharmaceutical University



  1. Experiment and Guide for Microbiology, 3rd edition, associate chief editor, 2015, Chinese Medical Science and Technology Press, 104-148, 230-231, 241-242, 245, 247-248

  2. Microbiology and Immunology, 8th edition, co-editor, 2015, People's Medical Publishing House, 396-437.

  3. Microbiology and Immunology, co-editor, 2013, Chinese Medical Science and Technology Press, 170-215.

  4. Pharmaceuticals of Bioengineering, co-editor, 2012, Science Press, 214-247

  5. Microbiology and Basic Immunology, 2nd edition, co-editor, 2008, Southeast University Press, 134-169.

Papers and Articles:

1.Study on β-Lactamase Genes in Multidrug-Resistant Acinetobacter baumannii and Insertion Sequence ISAba1,Pharmaceutical Biotechnology, 201522( 5): 407-411

2. Activity of Moxifloxacin against Resistant Staphylococcus Biofilms in Vitro. Pharmaceutical and Clinical Research, 201523(4)347-350

3. Pharmacokinetic /pharmacodynamic study of tebipenem pivoxil against Klebsiella pneumoniae in murine lung infection model, Chin J Clin Pharmacol, 2015, 31(4): 272-275

4. Activity of Linezolid against Methicillin -Resistant Staphylococcus aureus Biofilm and Its Antimicrobial Activity in Vitro and in Vivo, Pharmaceutical and Clinical Research, 2015, 23(3): 242-245

5. Establishment of MRSA Infection Model in Scald Mice and the Antibacterial Activity of a Novel Pleuromutilin Derivative WS-007,Pharmaceutical Biotechnology, 201421(5) : 416 - 419

6. Activity of S3, A Novel Pleuromutilin,against MRSA in Vitro and in Vivo,Pharmaceutical Biotechnology, 2013, 20( 6) : 510-513

7. Development of High-throughput Screening Assay for β-lactamase Inhibitor. Chinese Journal of Antibiotics, 2013, (38) 2: 102-105

8. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. The Journal of Antibiotics, 2012, 65(5):229-36

9. The Detection and Analysis of β-lactamase Produced by Nosocomial Gram-Negative Strains. Pharmaceutical Biotechnology 2012,19(5): 406-410

10. Comparative study on antibacterial activity of amoxicillin and piperacillin. Pharmaceutical Biotechnology, 2011,18 (4): 339-343

11. Preliminary study on the probioticcharacteristics of two strains of Bacillus Clausii in-vitro. Pharmaceutical Biotechnology, 2010, 17 (4) 321 – 325

12. Pharmacy year book, 2009, 25: 59-62